GSK net earnings moves up by 15.4 % in Q1 (PharmaBiz)

home   >   yahoo news

GlaxoSmithKline plc (GSK), the world's second largest pharma giant, achieved satisfactory financial performance during the first quarter ended March 2005 on account of strong sales growth in Europe and key growth drivers like Seretide/Advair and COPD. The company's total sales reached at £ 5,036 million in the first quarter of 2005 from £ 4855 million in the corresponding period of last year,

- link to GSK net earnings moves up by 15.4 % in Q1 (PharmaBiz) -
Last update: 05/26/2005

Recommended Reading

    Lamictal: (lamotrigine, GlaxoSmithKline).(New & approved: pravigard PAC, Lamictal) : An article from: Internal Medicine News
    Lamictal: (lamotrigine, GlaxoSmithKline).(New & approved: pravigard PAC, Lamictal) : An article from: Internal Medicine News
    Pravigard PAC.(New & Approved: Pravigard PAC, Lamictal) : An article from: Skin & Allergy News
    Beware potentially fatal skin reactions to lamictal. (One in 100 Children React to Antiepileptic).(Brief Article) : An article from: Pediatric News
    Lamotrigine approval for bipolar I hailed as a first: like 'mirror image of lithium'; drug helps prevent depressive episodes.(News) : An article from: Clinical Psychiatry News
    Pravigard PAC.(New & Approved: Pravigard PAC, Lamictal) : An article from: Skin & Allergy News
    Pravigard PAC.(New & Approved: Pravigard PAC, Lamictal) : An article from: Skin & Allergy News
    Life-threatening reactions reported with anticonvulsant lamotrigine. (Also Confused With Other Drugs). : An article from: Skin & Allergy News